Company / Shareholders' Equity
Steris Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$6.6B
FY2025
5-year range
$3.9B / $6.6B
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
#27 of 166
Health Care
What the data says
Steris's shareholders' equity of $6.6B is higher than 84% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from $2.8B in FY2017 to $6.6B in FY2025.
Based on SEC 10-K filings.
$6.6B in FY2025 with a 5-year CAGR of +14.2%. Top quartile in the Health Care sector.
Improved from $6.1B to $6.6B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Sector benchmark
+25.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +14.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 4.8% year-over-year.
- Ranks #27 out of 166 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.6B | +4.8% |
| FY2024 | $6.3B | +3.7% |
| FY2023 | $6.1B | -7.0% |
| FY2022 | $6.5B | +68.3% |
| FY2021 | $3.9B | +14.0% |
| FY2020 | $3.4B | +7.2% |
| FY2019 | $3.2B | -1.2% |
| FY2018 | $3.2B | +14.5% |
| FY2017 | $2.8B | -7.5% |
| FY2016 | $3.0B | - |
As of FY2025 · SEC 10-K · Updated Mar 13, 2026